Hematolojik Malignitelerde Kemoterapi Protokolleri
ISBN 978-605-68222-4-7

BRENTUXİMAB+DACARBAZIN

Kaynaklar:

1- Friedberg JW, Forero-Torres A, Bordoni RE, et al. Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL. Blood. 2017;130(26):2829–2837.